Average Co-Inventor Count = 5.56
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cephalon, Inc. (5 from 247 patents)
2. Rhone-poulenc Rorer Pharmaceuticals Inc. (4 from 111 patents)
3. Cancer Research Technology Limited (3 from 262 patents)
4. Other (1 from 832,843 patents)
5. Rorer Pharmaceutical Corporation (1 from 109 patents)
6. Ignyta, Inc. (25 patents)
14 patents:
1. 10954251 - Thienopyrimidine inhibitors of atypical protein kinase C
2. 10183950 - Thienopyrimidine inhibitors of atypical protein kinase C
3. 9604994 - Thienopyrimidine inhibitors of atypical protein kinase C
4. 9238656 - Imidazo[4,5-b]pyridine derivatives as ALK and JAK modulators for the treatment of proliferative disorders
5. 8552186 - Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors
6. 8354414 - Substituted bicyclic pyrimidines
7. 8148391 - Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors
8. 7851468 - Substituted pyrazolo[3,4-d]pyrimidines
9. 5596020 - Amino bi- and tri-carbocyclic alkane bis-aryl squalene synthase
10. 5451596 - Cycloalkyl amine bis-aryl squalene synthase inhibitors
11. 5395846 - Amino Bi- and tri-carbocyclic aklane bis-aryl squalene synthase
12. 5082849 - Quinolinyl-benzopyran derivatives as antagonists of leukotriene D4
13. 5041453 - Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene
14. 4977162 - Quinolinyl-chromone derivatives and use for treatment of hypersensitive